Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials
文献类型：期刊论文
| 刊名 | CHINESE MEDICAL JOURNAL
 |
| 出版日期 | 2014 |
| 卷号 | 127 |
| 关键词 | PHASE-II TRIAL SUPPORTIVE CARE 1ST-LINE TREATMENT PLUS CISPLATIN FOLINIC ACID 5-FLUOROURACIL LEUCOVORIN ADENOCARCINOMA FLUOROURACIL CARCINOMA irinotecan gastric cancer meta-analysis |
| ISSN号 | 0366-6999 |
| 其他题名 | Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials |
| 英文摘要 | Background Studies have shown that irinotecan can improve survival in patients with advanced or recurrent gastric cancer, but the overall benefit of irinotecan in the treatment of advanced or recurrent gastric cancer remains controversial. The aim of this study was to evaluate the benefits and risks of irinotecan for survival in patients with advanced or recurrent gastric cancer. |
| 语种 | 英语 |
| CSCD记录号 | CSCD:5069558 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/52820]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 推荐引用方式 GB/T 7714 | . Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials[J]. CHINESE MEDICAL JOURNAL,2014,127. |
| APA | (2014).Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials.CHINESE MEDICAL JOURNAL,127. |
| MLA | "Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials".CHINESE MEDICAL JOURNAL 127(2014). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。